Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice
Author(s) -
Roger V. Ortines,
Yu Wang,
Haiyun Liu,
Dustin Dikeman,
Bret L. Pinsker,
Robert J. Miller,
Sophia E. Kim,
Nicole E. Ackerman,
Joe F. Rizkallah,
LeeAnn T. Marcello,
Taylor S. Cohen,
Christine Tkaczyk,
Bret R. Sellman,
Lloyd Miller
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00346-19
Subject(s) - staphylococcus aureus , monoclonal antibody , microbiology and biotechnology , vancomycin , micrococcaceae , medicine , staphylococcal infections , antibody , monoclonal , methicillin resistant staphylococcus aureus , antibiotics , antibacterial agent , immunology , biology , bacteria , genetics
Surgical site infections (SSIs) are commonly caused byStaphylococcus aureus . We report that a combination of three monoclonal antibodies (MEDI6389) that neutralizeS. aureus alpha-toxin, clumping factor A, and four leukocidins (LukSF, LukED, HlgAB, and HlgCB) plus vancomycin had enhanced efficacy compared with control antibody plus vancomycin in two mouse models ofS. aureus SSI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom